Incidence of end-stage renal disease and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes: the Fukuoka Diabetes Registry

被引:8
|
作者
Iwase, Masanori [1 ,2 ,3 ]
Ide, Hitoshi [1 ,2 ,3 ]
Ohkuma, Toshiaki [1 ]
Fujii, Hiroki [1 ]
Komorita, Yuji [1 ]
Yoshinari, Masahito [1 ]
Oku, Yutaro [1 ]
Higashi, Taiki [1 ]
Nakamura, Udai [1 ,4 ]
Kitazono, Takanari [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, Maidashi 3-1-1, Fukuoka 8128582, Japan
[2] Hakujyuji Hosp, Diabet Ctr, Fukuoka, Japan
[3] Hakujyuji Hosp, Clin Res Ctr, Fukuoka, Japan
[4] Steel Mem Yawata Hosp, Diabet Ctr, Kitakyushu, Fukuoka, Japan
基金
日本学术振兴会;
关键词
Depression; Diabetic kidney disease; Dietary fiber; Lifestyle; Physical activity; Prospective study; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR EVENTS; CKD; INSUFFICIENCY; ALBUMINURIA;
D O I
10.1007/s10157-021-02136-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Epidemiological data regarding diabetic kidney disease are accumulated insufficiently in Japan. We prospectively investigated the incidence of end-stage renal disease (ESRD) and risk factors for progression of renal dysfunction in Japanese patients with type 2 diabetes. Methods 4904 participants with type 2 diabetes (mean age 65 years, mean estimated glomerular filtration rate (eGFR) 75 mL/min/1.73 m(2), proportion of eGFR < 60 mL/min/1.73 m(2) 21%) were investigated for the progression to ESRD requiring dialysis in multicenter outpatients registry for 5 years. Risk factors for progression of renal dysfunction (>= 30% decline in eGFR from the baseline and annual eGFR decline rates) were evaluated. Results The incidence rates of ESRD and all-cause mortality were 4.1/1000 person-years and 12.3/1000 person-years, respectively, and increased according to stages of chronic kidney disease (eGFR < 30 mL/min/1.73 m(2), incidence of ESRD 176.6/1000 person-years, all-cause mortality 57.4/1000 person-years). Incidence of >= 30% decline in eGFR from the baseline was 16.4% at 5 years, and the mean annual decline rate was -1.84 mL/min/1.73 m(2)/year. The progression of renal dysfunction was significantly associated with older age, poor glycemic control, blood pressure, albuminuria, eGFR, previous cardiovascular disease, lifestyle factors (body mass index, reduced intake of dietary fiber, increased intake of sodium, no regular exercise), and depressive symptoms. Conclusions This prospective study has emphasized the importance of multifactorial interventions on risk factors to suppress the high incidence of ESRD in Japanese patients with type 2 diabetes.
引用
收藏
页码:122 / 131
页数:10
相关论文
共 50 条
  • [41] Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients
    Zhao, Lijun
    Zou, Yutong
    Zhang, Junlin
    Zhang, Rui
    Ren, Honghong
    Lin, Li
    Guo, Ruikun
    Zhang, Jie
    Liu, Fang
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2020, 17 (14): : 2113 - 2124
  • [42] The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitus
    Postma, Maarten J.
    de Zeeuw, Dick
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (10) : 2975 - 2983
  • [43] Efficacy of Saxagliptin versus Mitiglinid in patients with type 2 diabetes and end-stage renal disease
    Sakai Y.
    Sakai S.
    Mugishima K.
    Katayama A.
    Sumi Y.
    Otsuka Y.
    Otsuka T.
    Tsuruoka S.
    Renal Replacement Therapy, 3 (1)
  • [44] The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes
    Zoungas, Sophia
    Kerr, Peter G.
    Lui, Michelle
    Teede, Helena J.
    NEPHROLOGY, 2008, 13 (02) : 124 - 127
  • [45] Incidence of diabetic foot ulcer in Japanese patients with type 2 diabetes mellitus: The Fukuoka diabetes registry
    Iwase, Masanori
    Fujii, Hiroki
    Nakamura, Udai
    Ohkuma, Toshiaki
    Ide, Hitoshi
    Jodai-Kitamura, Tamaki
    Sumi, Akiko
    Komorita, Yuji
    Yoshinari, Masahito
    Kitazono, Takanari
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 137 : 183 - 189
  • [46] Secular trends in the incidence of end-stage renal disease and its risk factors in Japanese patients with immunoglobulin A nephropathy
    Tanaka, Shigeru
    Ninomiya, Toshiharu
    Katafuchi, Ritsuko
    Masutani, Kosuke
    Tsuchimoto, Akihiro
    Tokumoto, Masanori
    Hirakata, Hideki
    Ooboshi, Hiroaki
    Kitazono, Takanari
    Tsuruya, Kazuhiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (06) : 963 - 971
  • [47] DISPARITIES IN INCIDENCE OF DIABETIC END-STAGE RENAL-DISEASE ACCORDING TO RACE AND TYPE OF DIABETES
    COWIE, CC
    PORT, FK
    WOLFE, RA
    SAVAGE, PJ
    MOLL, PP
    HAWTHORNE, VM
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (16): : 1074 - 1079
  • [48] The impact of renal transplantation on the incidence of congestive heart failure in patients with end-stage renal disease due to diabetes
    Abbott, KC
    Hypolite, IO
    Hshieh, P
    Cruess, D
    Agodoa, LYC
    Welch, PG
    Taylor, AJ
    Yuan, CM
    JOURNAL OF NEPHROLOGY, 2001, 14 (05) : 369 - 376
  • [49] Diabetes and the risk of end-stage renal disease (ESRD) in the United States
    Tarver-Carr, ME
    Powe, NR
    Eberhardt, MS
    Brancati, FL
    DIABETES, 2000, 49 : A190 - A190
  • [50] Clinical predictive factors and prediction models for end-stage renal disease in Chinese patients with type 2 diabetes mellitus
    Gao, Yueming
    Shang, Zhi
    Nie, Sheng
    Feng, Songtao
    Wang, Bin
    Li, Zuolin
    Wu, Min
    Wen, Yi
    Xu, Hong
    Weng, Jianping
    Chen, Chunbo
    Liu, Huafeng
    Yang, Qiongqiong
    Li, Hua
    Kong, Yaozhong
    Li, Guisen
    Wan, Qijun
    Zha, Yan
    Hu, Ying
    Xu, Gang
    Shi, Yongjun
    Zhou, Yilun
    Su, Guobin
    Tang, Ying
    Gong, Mengchun
    Fan, Hou Fan
    Liu, Bicheng
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (07):